Predictive factors associated with involved margins in breast cancer treated with neoadjuvant chemotherapy followed by breast-conserving therapy

被引:5
作者
Davoine, Elise [1 ,2 ]
Dion, Ludivine [1 ,2 ]
Timoh, Krystel Nyangoh [1 ,2 ]
Beraud, Eugenie [4 ]
Tas, Patrick [5 ,6 ]
Tavenard, Aude [7 ]
Laviolle, Bruno [7 ]
Perrin, Christophe [8 ]
Foucher, Fabrice [1 ]
Leveque, Jean [1 ,2 ,3 ]
Lavoue, Vincent [1 ,2 ,3 ]
机构
[1] Rennes Univ Hosp, Gynecol Dept, Hop Sud, 16 Bd Bulgarie, F-35000 Rennes, France
[2] Univ Rennes 1, Fac Med, 2 Rue Henri Le Guilloux, F-35000 Rennes, France
[3] INSERM, ER440 OSS, CRLCC Eugene Marquis, Rennes, France
[4] Rennes Univ Hosp, Radiol Dept, Hop Sud, 16 Bd Bulgarie, F-35000 Rennes, France
[5] Eugene Marquis Comprehens Canc Ctr, Pathol Dept, Ave Bataille Flandres Dunkerque, F-35000 Rennes, France
[6] Rennes Univ Hosp, Pathol Dept, 2 Rue Henri Le Guilloux, F-35000 Rennes, France
[7] Rennes Univ Hosp, Clin Res Dept, 2 Rue Henri Le Guilloux, F-35000 Rennes, France
[8] Eugene Marquis Comprehens Canc Ctr, Med Oncol Dept, Ave Bataille Flandres Dunkerque, F-35000 Rennes, France
关键词
Neoadjuvant chemotherapy; Breast-Conserving; Surgery; CARCINOMA IN-SITU; SURGICAL ADJUVANT BREAST; PREOPERATIVE CHEMOTHERAPY; RANDOMIZED-TRIAL; RE-EXCISION; SURGERY; WOMEN; LUMPECTOMY; TUMORS; METAANALYSIS;
D O I
10.1016/j.jogoh.2019.06.005
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: : This study sought to identify predictive factors of involved surgical margins in breast-conserving surgery (BCS) after neoadjuvant chemotherapy (NAC) to help guide the surgical procedure. Materials and Methods: : Retrospective study of patients who had BCS after NAC between January 2008 and December 2013. Outcome measure: tumor-involved margin, defined by tumor cells on ink for invasive cancer and tumor-free margin < 2 mm for DCIS. Results: : Ninety-seven patients were included. The median age of patients was 46 years old [28-71]. The initial average tumor size was 47.8 mm [+/- 18.6]. Twelve patients (12.4%) had involved tumor margins on final histology after BCS and NAC. According to the multivariate model including only preoperative variables of positive margins, initial ultrasound tumor size <= 27 mm (p = 0.045) and low SBR grade (p = 0.009) were independently associated with tumor-involved margins. According to the multivariate model including pre- and postoperative variables of positive margins, ductal carcinomain situ was also independently associated with tumor-involved margins (p = 0.021). Conclusion: : Initial ultrasound tumor size <= 27 mm and low SBR grade were independently associated with tumor-involved margins. These preoperative data were very helpful to guide the surgical procedure in breast cancer. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:467 / 472
页数:6
相关论文
共 45 条
[1]   Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy [J].
Aas, T ;
Geisler, S ;
Eide, GE ;
Haugen, DF ;
Varhaug, JE ;
Bassoe, AM ;
Thorsen, T ;
Berntsen, H ;
Borresen-Dale, AL ;
Akslen, LA ;
Lonning, PE .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (04) :438-446
[2]  
Amat S, 2002, INT J ONCOL, V20, P791
[3]   Optimizing Surgical Margins in Breast Conservation [J].
Ananthakrishnan, Preya ;
Balci, Fatih Levent ;
Crowe, Joseph P. .
INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY, 2012, 2012
[4]  
[Anonymous], ANN SURG ONCOL
[5]   Surgical margins and risk of locoregional recurrence in invasive breast cancer: An analysis of 10-year data from the Breast Cancer Treatment Quality Assurance Project [J].
Behm, Eirene C. ;
Beckmann, Kerri R. ;
Dahlstrom, Jane E. ;
Zhang, Yanping ;
Cho, Carolyn ;
Stuart-Harris, Robin ;
Craft, Paul ;
Rezo, Angela ;
Buckingham, John M. .
BREAST, 2013, 22 (05) :839-844
[6]   Breast-conserving therapy after neoadjuvant chemotherapy: Long-term results [J].
Beriwal, S ;
Schwartz, GF ;
Komarnicky, L ;
Garcia-Young, JA .
BREAST JOURNAL, 2006, 12 (02) :159-164
[7]   PRIMARY CHEMOTHERAPY TO AVOID MASTECTOMY IN TUMORS WITH DIAMETERS OF 3 CENTIMETERS OR MORE [J].
BONADONNA, G ;
VERONESI, U ;
BRAMBILLA, C ;
FERRARI, L ;
LUINI, A ;
GRECO, M ;
BARTOLI, C ;
DEYOLDI, GC ;
ZUCALI, R ;
RILKE, F ;
ANDREOLA, S ;
SILVESTRINI, R ;
DIFRONZO, G ;
VALAGUSSA, P .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (19) :1539-1545
[8]   Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma May Not Improve Rates of Breast Conservation [J].
Boughey, Judy C. ;
Wagner, Jamie ;
Garrett, Betsy J. ;
Harker, Lori ;
Middleton, Lavinia P. ;
Babiera, Gildy V. ;
Meric-Bernstam, Funda ;
Lucci, Anthony ;
Hunt, Kelly K. ;
Bedrosian, Isabelle .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (06) :1606-1611
[9]   Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy [J].
Brain, E ;
Garrino, C ;
Misset, JL ;
Carbonero, IG ;
Itzhaki, M ;
Cvitkovic, E ;
Goldschmidt, E ;
Burki, F ;
Regensberg, C ;
Pappo, E ;
Hagipantelli, R ;
Musset, M .
BRITISH JOURNAL OF CANCER, 1997, 75 (09) :1360-1367
[10]   Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: A National Cancer Institute conference [J].
Buchholz, Thomas A. ;
Lehman, Constance D. ;
Harris, Jay R. ;
Pockaj, Barbara A. ;
Khouri, Nagi ;
Hylton, Nola F. ;
Miller, Michael J. ;
Whelan, Timothy ;
Pierce, Lori J. ;
Esserman, Laura J. ;
Newman, Lisa A. ;
Smith, Barbara L. ;
Bear, Harry D. ;
Mamounas, Eleftherios P. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (05) :791-797